About Zeiss Pharma Limited
Data last updated:
Zeiss Pharma Limited is a public limited company based in Panchkula, Haryana, India, a subsidiary of Zeiss Pharmaceuticals Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233HR2014PLC052139. Its GSTIN is 06AAACZ7511N2ZZ (Haryana). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹14.05 Cr. It is led by directors including Vikas Gupta (Whole-Time Director) and Satyapal Bansal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 4th Floor Plot No.16 Sector 22 IT Park, Panchkula, Haryana, India – 134109.
As per the financials filed for FY 2025, the company reported a revenue of ₹310.78 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹25.74 Cr (net margin 8.3%) and EBITDA of ₹45.67 Cr (EBITDA margin 14.7%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 18% over five years.
The company has about 155 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹190.23 Cr on record. Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it; 3 cases are pending. The company has 1 deal on record (1 rights issue); the latest was in February 2016. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Softgel Healthcare Private Limited with revenue of ₹327.36 Cr. The company has 6 MSME Form 1 returns on record between 2019 and 2022, listing 706 overdue payments to 58 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zpharma.co.in.
Company details
Contact details
Zeiss Pharma Limited's registered office is in Panchkula, Haryana. Its website is zpharma.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address4th Floor Plot No.16 Sector 22 IT Park, Panchkula, Haryana, India – 134109
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Zeiss Pharma Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zeiss Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Zeiss Pharma Limited, buy the company report.
Financials of Zeiss Pharma Limited
FY 2024 filings availableZeiss Pharma Limited reported revenue of ₹310.78 Cr (up 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 13% growth in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹45.67 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹25.74 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.7% | ||||
| Net Profit Margin | 8.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zeiss Pharma Limited, buy the company report.
Board of directors and KMP of Zeiss Pharma Limited
Zeiss Pharma Limited currently reports 4 directors and 1 key managerial person. 3 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyapal Bansal Also directs: Bansal Finefoods Private Limited | Director | 25 Apr 2016 | 10 Years 5 Months | Current |
| Neeraj Bansal Also directs: Bansal Finefoods Private Limited | Director | 25 Apr 2016 | 10 Years 5 Months | Current |
| Sat Pal Also directs: Zeiss Pharmaceuticals Private Limited | Director | 13 Mar 2014 | 12 Years 7 Months | Current |
| Vikas Gupta Also directs: Zeiss Pharmaceuticals Private Limited, Mczeiss Life Science LLP | Whole-Time Director | 13 Mar 2014 | 12 Years 7 Months | Current |
| Vinij Gupta Also directs: Zeiss Pharmaceuticals Private Limited | Cfo | 24 Apr 2016 | 10 Years 5 Months | Current |
Peer comparison
Zeiss Pharma Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Softgel Healthcare Private Limited | ₹327.36 Cr (FY 2025) | 42.0% | Puduppakkam, Tamil Nadu, India | |||
| Overseas Health Care Private Limited | ₹323.03 Cr (FY 2025) | 22.0% | Punjab, India | |||
| Gopaldas Visram and Company Limited | ₹322.71 Cr (FY 2025) | 15.0% | Mumabi, Maharashtra, India | |||
| Zeiss Pharma Limitedthis company | ₹310.78 Cr (FY 2025) | ₹25.74 Cr | 8.3% | 13.0% | 155 | Panchkula, Haryana, India |
| Ultra Drugs Private Limited | ₹308.31 Cr (FY 2024) | 24.0% | Chandigarh, India | |||
| Ciron Drugs and Pharmaceuticals Private Limited | ₹304.93 Cr (FY 2024) | 15.0% | Mumbai, Maharashtra, India | |||
| Galpha Laboratories Limited. | ₹302.27 Cr (FY 2025) | -7.0% | Patna, Bihar, India | |||
| Aagya Biotech Private Limited | ₹298.87 Cr (FY 2024) | -8.0% | Roorkee, Uttarakhand, India | |||
| Somerset Therapeutics Private Limited | ₹297.65 Cr (FY 2025) | 35.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Zeiss Pharma Limited, buy the company report.
Auditor
Zeiss Pharma Limited is audited by VINEY GOEL & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VINEY GOEL & ASSOCIATES | FY 2024 | 012188N |
Shareholding
The shareholding of Zeiss Pharma Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Zeiss Pharma Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Aug 2017 | 100136360 | Hdfc Bank Limited | ₹10 Cr | Open | |
| 30 Nov 2015 | 10614311 | Hdfc Bank Limited | ₹180.23 Cr | Open |
To see the full charge records of Zeiss Pharma Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Zeiss Pharma Limited has 1 deal on record (1 rights issue); the latest was in February 2016.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2016 | Rights issue | ₹14 Cr | Investors: Zeiss Pharmaceuticals Private Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Zeiss Pharma Limited has 4 court cases on record: 2 filed by Zeiss Pharma, 2 filed against it. 3 cases are pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 2 |
| High courts | 2 | 0 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, JAMMUKASHMIR | Writ petition | Filed by the company against Union Territory of Jammu and Kashmir Th Financial Commissioner and Another | Pending |
| District court, TUMAKURU, Karnataka | Criminal miscellaneous application | Filed against the company by State at the Instance of Assistant Drugs Controller-2 | Pending |
| District court, Budaun, Uttar Pradesh | Court case (Crl .Misc.) | Filed against the company by State Government | Pending |
| High Court, JAMMUKASHMIR | Writ petition | Filed by the company against State of J and K Th. Principal Secretary Fonance Deptt. and Ors. | Disposed |
To see the full case history of Zeiss Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Zeiss Pharma Limited has 6 MSME Form 1 returns on record between 2019 and 2022, listing 706 overdue payments to 58 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 58)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Elmach Packages (India) Private Limited | |||
| KC Overseas Private Limited | |||
| Kartonz | |||
| Krishna Printers | |||
| Bharadwaj Industries |
To see the full MSME payment records of Zeiss Pharma Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Zeiss Pharma Limited has a workforce of 155 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
GST
Zeiss Pharma has 5 GST registrations: 4 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACZ7511N2ZZ | Haryana | Active | 16 Nov 2019 |
| 01AAACZ7511N1ZA | Jammu and Kashmir | Active | 08 Jul 2017 |
| 01AAACZ7511N2Z9 | Jammu and Kashmir | Active | 17 Feb 2019 |
| 01AAACZ7511N3Z8 | Jammu and Kashmir | Active | 02 Dec 2022 |
To see the full GST registrations and return filing status of Zeiss Pharma Limited, buy the company report.
Recent activity
Zeiss Pharma Limited has 6 board changes on record since 2014: 5 appointments and 1 cessation. The latest: Neeraj Bansal was appointed as Director on 25 Apr 2016.
Frequently asked questions
Zeiss Pharma is an active public limited company based in Panchkula, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 March 2014 (12+ years old) and is registered under CIN U24233HR2014PLC052139.
Zeiss Pharma has 5 current directors and KMP:
- Vikas Gupta - Whole-Time Director
- Satyapal Bansal - Director
- Neeraj Bansal - Director
- Sat Pal - Director
- Vinij Gupta - Cfo
The latest financial statements of Zeiss Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Zeiss Pharma is 06AAACZ7511N2ZZ, registered in Haryana. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 01AAACZ7511N1ZA (Jammu and Kashmir), 01AAACZ7511N2Z9 (Jammu and Kashmir), 01AAACZ7511N3Z8 (Jammu and Kashmir).
The CIN (Corporate Identification Number) of Zeiss Pharma is U24233HR2014PLC052139. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zeiss Pharma has 4 court cases on record: 2 filed by the company and 2 filed against it. 3 are pending. Most are in the district courts.
Zeiss Pharma was incorporated on 13 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
Zeiss Pharma has 1 deal on record (1 rights issue); the latest was in February 2016.
The peers of Zeiss Pharma by revenue are Softgel Healthcare Private Limited, Overseas Health Care Private Limited, Gopaldas Visram and Company Limited, Ultra Drugs Private Limited, Ciron Drugs and Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Neeraj Bansal was appointed as Director on 25 Apr 2016. Satyapal Bansal was appointed as Director on 25 Apr 2016. Vikas Gupta ceased to be Director on 24 Apr 2016. Zeiss Pharma has 6 board changes on record in total.
Zeiss Pharma has 6 MSME Form 1 returns on record between 2019 and 2022, listing 706 overdue payments to 58 micro and small suppliers. The latest return was filed on 15 Nov 2022.
Zeiss Pharma can be reached through the website zpharma.co.in. Its registered office is in Panchkula, Haryana, India.